BNP Paribas Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-204,630
Closed -$8.62M 871
2023
Q2
$8.62M Sell
204,630
-41,370
-17% -$1.67M 0.03% 423
2023
Q1
$8.76M Buy
+246,000
New +$8.93M 0.03% 442

Other funds holding SYNH

BNP Paribas Asset Management's SYNH Position: Q3 2023 in Review

BNP Paribas Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 204,630 shares — an estimated $8.62M sold.

BNP Paribas Asset Management first reported a position in SYNH in Q1 2023 and held it in 2 quarters. The position peaked at $8.76M in Q1 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • BNP Paribas Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • BNP Paribas Asset Management sold 204,630 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $8.62M.
  • BNP Paribas Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2023 and held it in 2 quarters.
  • BNP Paribas Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $8.76M in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on BNP Paribas Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.